In this webinar, Prof. Faraone will provide a comprehensive introduction to attention deficit hyperactivity disorder in adults.   It will begin with an overview of what is known about the etiology and neurobiology of the disorder with an emphasis on what the implications of these data are for clinical practice.  He will explain how new genetic data have changed our conceptualization of the disorder and its relationship with other psychiatric disorders and with somatic disorders.  The genetic section will address the utility, or lack thereof of pharmacogenetics for choosing medications for those with ADHD.   A section on diagnosis addresses these issues: how to screen for ADHD in adults, key features and limitations of the DSM 5 diagnosis of ADHD, the role of emotional symptoms in diagnosing ADHD, how to evaluate late diagnosed ADHD of, apparently, adult onset.  A section on pharmacologic treatment addresses: a treatment algorithm addressing pharmacologic and nonpharmacologic treatments, the range of medications available for ADHD along with evidence for efficacy and tolerability, medication effects on real world outcomes, and the nonmedical use of prescribed stimulants.   A section on nonpharmacologic treatments addresses a range of treatments including cognitive behavior therapy, omega-3 fatty acid supplementation, meditation based therapies and exercise.  The webinar ends with a discussion of the Adult ADHD Quality Measures Project headed by Prof Faraone.

Learning objectives:

Participants will be able to

• Describe the latest research on the etiology and neurobiology of ADHD
• Explain the genetic relationship to other psychiatric disorders
• Consider Treatment options, including pharmacology
• Apply diagnostic Processes in ADHD
• Critique screening for ADHD in adults, including limitations of the DSM-5

hose viewing the recorded webinar will still be eligible for continuing education credits. Earn 3 Continuing Education (CE) credits from the Canadian Psychological Association for attending this event.

Build Great Teams is approved by the Canadian Psychological Association to offer continuing education for psychologists. Build Great Teams maintains responsibility for the program. The CPA’s approval of an individual, group, or organization as a CE Sponsor or Provider is restricted to the activities described in the approved application or annual report form. The CPA’s approval does not extend to any other CE activity the Sponsor or Provider might offer. In granting its approval, the CPA assumes no legal or financial obligations to Sponsors, Providers, or to those individuals who might participate in a Sponsor or Provider’s CE activities or programs. Further, responsibility for the content, provision, and delivery of any CE activity approved by the CPA remains that of the CE Sponsor or Provider. The CPA disclaims all legal liability associated with the content, provision, and delivery of the approved CE activity.